IM Cannabis Corp. (IMCC)
1.54
0.05 (3.36%)
At close: Apr 17, 2025, 3:40 PM
1.46
-4.90%
After-hours: Apr 17, 2025, 05:31 PM EDT
Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada.
It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands.
The company serves medical patients and adult-use recreational consumers.
IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
IM Cannabis Corp.
| Country | IL |
| IPO Date | May 20, 2020 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: Kibbutz Glil Yam Tel Aviv, IL | |
| Website | https://www.imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001792030 |
| CUSIP Number | 44969Q208 |
| ISIN Number | CA44969Q3070 |
| Employer ID | 00-0000000 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Eyal Fisher | Chief Executive Officer & GM of the IMC Holdings |
| Oren Shuster | Executive Chairman & Chief Executive Officer |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Uri Birenberg | Chief Financial Officer |
| Advocate Michal Lebovitz Nissimov | General Counsel & Secretary |
| Anna Taranko | Director Investor & Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 11, 2025 | 6-K | Filing |
| Apr 03, 2025 | 6-K | Filing |
| Mar 31, 2025 | 6-K | Filing |
| Mar 31, 2025 | 20-F | Filing |
| Mar 20, 2025 | 6-K | Filing |
| Mar 05, 2025 | 6-K | Filing |
| Feb 05, 2025 | 6-K | Filing |
| Jan 17, 2025 | 6-K | Filing |
| Jan 06, 2025 | 6-K | Filing |
| Dec 04, 2024 | 6-K | Filing |